Media coverage
10
Media coverage
Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Business Wire Country/Territory United States Date 4/10/21 URL www.businesswire.com/news/home/20211004005317/en Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021; Not intended for UK and U.S. based media Media name/outlet Business Wire Country/Territory United States Date 4/10/21 Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Yahoo! Finance Country/Territory United States Date 4/10/21 URL https://finance.yahoo.com/news/merck-completes-enrolment-evobrutinib-phase-070000912.html Persons Deirdre Bennett Title Merck : Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet MarketScreener.com Country/Territory United States Date 4/10/21 URL https://www.marketscreener.com/news/latest/Merck-Completes-Enrolment-of-Evobrutinib-Phase-III-Clinical-Trials-Ahead-of-ECTRIMS-2021--36591243/ Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet TD Ameritrade Country/Territory United States Date 4/10/21 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-277b6961 Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet ADVFN US Country/Territory United States Date 4/10/21 URL https://www.advfn.com/p.php?pid=nmona&article=86199628 Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 4/10/21 URL https://www.finanznachrichten.de/nachrichten-2021-10/54104317-merck-completes-enrolment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021-004.htm Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet BizWire Express Country/Territory India Date 4/10/21 URL www.bizwireexpress.com/showstorybwi.php?storyid=33398 Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Digital Media Net Country/Territory United States Date 4/10/21 URL dmnnewswire.digitalmedianet.com/2021/10/04/merck-completes-enrolment-of-evobrutinib-phase-iii-clinical-trials-ahead-of-ectrims-2021/ Persons Deirdre Bennett Title Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021 Media name/outlet Acrofan Date 3/10/21 URL https://us.acrofan.com/detail.php?number=540528 Persons Deirdre Bennett